قالب وردپرس درنا توس
Home / Business / Oxford University stops trials of AstraZeneca COVID vaccine in children and adolescents due to blood clotting problems

Oxford University stops trials of AstraZeneca COVID vaccine in children and adolescents due to blood clotting problems



Oxford University has suspended the use of the COVID-19 vaccine dose developed by AstraZeneca PLC AZN,
-0.13%
AZN,
+ 0.15%
The Wall Street Journal reported on Tuesday that in a small UK study designed to evaluate its safety and effectiveness in children and adolescents, it is waiting for information on the rare occurrence in a small group of adults receiving the treatment. Further information on clotting problems. The newspaper said that the trial began in mid-February and involved more than 200 young people between the ages of 6 and 1

7. It quoted a spokesperson from the University of Oxford as saying that the trial did not find any safety issues, but behind the move was the extensive attention and review of the vaccine by the UK and EU regulators. The European Medicines Agency (European Medicines Agency) said earlier that it hopes to update its investigation of the clotting problem with the public later this week.


Source link